Regulatory/Legislative News

The U.S. Court of Appeals for the Federal Circuit has struck down Allergan’s attempt to use tribal sovereignty to avoid a patent challenge on Restasis.

On July 24, the U.S. House of Representatives passed the Protect Medical Innovation Act by a vote of 238-132. This bipartisan legislation permanently repeals the excise tax on medical devices described in the Affordable Care Act.

The FDA has approved two investigational device exemption applications for pilot studies of EyeGate’s ocular bandage gel, the company announced in a press release.

The Foundation Fighting Blindness is urging Congress to pass a bill that aims to speed up cures for blindness by allowing the creation of “Eye-Bonds,” according to a press release.

The European Patent Office has revoked the MicroPulse patent held by Iridex, according to a press release from OD-OS.

Here are some recent top articles on Healio.com/OSN:

The FDA has issued approvals and clearances and closed out warning letters in recent weeks regarding multiple companies and products in the ophthalmology industry.

To mark Dry Eye Awareness Month and highlight the 2017 publication of the Tear Film & Ocular Surface Society’s Dry Eye Workshop II, TFOS and the Alliance for Eye and Vision Research will host a congressional briefing today.

The FDA has issued 510(k) clearance of Alleye, a mobile medical software application, Oculocare medical announced in a press release.

A new drug application for Bausch + Lomb’s sub-micron loteprednol etabonate ophthalmic gel 0.38% has been accepted by the FDA, the company announced.